Best Herd Immunity Podcasts (2025)

1
Episode 15: Protection, Interrupted: How Chasing Sterilizing Immunity Fails the Herd 30:05

2d ago30:05

30:05

What if our biggest mistake in vaccine communication wasn’t misinformation—but misexpectation? In this episode of Infectious Dose, Heather digs into the seductive myth of sterilizing immunity—the idea that a “perfect” vaccine blocks infection completely—and explores how this scientific fable has distorted public expectations, undermined trust, and …

1
MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management 1:03:44

7h ago1:03:44

1:03:44

In this CEC Oncology recorded, case-based symposium, expert faculty will discuss diagnosis and disease challenges over a person’s lifespan; explore the integration of MEK inhibitors in the management of NF1-associated PNs in pediatric patients; and consider comprehensive interprofessional care plans that include disease monitoring, toxicity managem…

1
Episode 14: No Name, No Mercy: The Hantavirus That Killed Betsy Arakawa 1:09:29

9d ago1:09:29

1:09:29

In this episode, Heather delves into the story of Sin Nombre virus and the disease it causes, Hantavirus Pulmonary Syndrome. From its rodent origins and rapid progression to the public health response and scientific breakthroughs that followed, we explore how a rare virus rewrote the rules of infectious disease in North America—and why it remains a…

1
Episode 13: Un-Vaccinated - the Global Measles Emergency 1:06:50

16d ago1:06:50

1:06:50

Heather gives updates on 2025 measles outbreaks in every region of the world and discusses global efforts to curb them. She also debunks the deadly lies about measles from RFK Jr. in her fan favorite segment WTF-RFK! and answers listener questions in her new segment Hot Zone Hotline. Explicit rating is for mild and limited profanity because, I mean…

1
Episode 12: Vaccine Safety 6 - Expecting Protection: Building vaccine confidence for moms-to-be 49:53

23d ago49:53

49:53

Pregnant and wondering which vaccines are safe? Heather separates myths from facts & shares exactly what science says about vaccine safety during pregnancy—because you and your baby deserve the best protection!By Infectious Dose

1
Episode 11: Close Quarters, Silent Threat - Invasive Meningococcal Disease in Dorms and Barracks 54:24

30d ago54:24

54:24

Invasive meningococcal disease strikes fast—and often without warning—especially in close-contact environments like college dorms and military barracks. While it’s rare, the consequences can be devastating: death within hours, or lifelong complications like limb loss and brain damage. In this episode Heather explains all about how Neisseria meningi…

1
Episode 10: Vaccine Safety 5 - Inside the Vial: the Truth About What’s Actually in Vaccines 41:19

1M ago41:19

41:19

In the 5th episode in her vaccine safety series, Heather gives straightforward, science-based answers to some of the most common questions about what’s in vaccines including an in-depth look at what's in several specific vaccines and the truth debunking false claims you've seen recently in the media.…

1
Episode 9: Sleeper Cells - How Anthrax Hides, Strikes, and Could One Day Heal 42:22

1M ago42:22

42:22

Anthrax is one of the oldest infectious diseases known to science. Its ability to survive harsh environments and reemerge as a deadly pathogen centuries later is a biological marvel—and a global health concern. Heather covers all you want to know about anthrax from its formidable spore structure and use as a bioweapon, to its recent outbreaks and p…

1
Episode 8: Vaccine Safety 4 - The Vaccine Court and Adjudication of Autism Cases 34:38

2M ago34:38

34:38

Heather digs in to the truth about the vaccine court and how its history of claims supports that vaccines are safe! Explicit rating for mild, limited profanity.By Infectious Dose

1
Episode 7: Fowl on the Play as Bird Flu Heats Up 26:48

2M ago26:48

26:48

Is bird flu’s resurgence a warning sign worth heeding? Heather digs into the science, the stakes, and what this latest avian alarm could mean for global health. Explicit rating for mild, limited profanity.By Infectious Dose

1
Episode 6: Vaccine Safety 3 - Too Many Too Soon? 17:12

2M ago17:12

17:12

Heather goes in-depth on why the current vaccine schedule is safe and effective for children and newborns. Infectiousdose.com Marked explicit for possible limited, mild profanity.By Infectious Dose

1
Episode 5: The Monster That is Measles 35:32

2M ago35:32

35:32

Heather delivers the scoop on the disease caused by measles, including symptoms, transmission, prevention, treatment, what's in the very safe vaccines, and dangerous complications and long-term health problems of natural infection. Marked explicit for possible limited, mild profanity.By pathogenperspectives

1
Episode 4: Vaccine Safety 2 - The Continuing Crimes of Andrew Wakefield 21:22

2M ago21:22

21:22

In the second vaccine safety episode, Heather describes how Andrew Wakefield's fraudulent science cost the world the elimination of measles and hurt children. With evidence to back it up, she goes into detail on what he did and how he still manipulates parents fears to make money. Marked explicit for limited and mild profanity.…

1
Episode 3: Vaccine Safety 1- Vaccines do NOT Cause Autism 17:03

2M ago17:03

17:03

In the first of several episodes on vaccine safety, Heather explains how we know vaccines are safe and do not cause autism. She provides all her sources and links in the corresponding blog post at Infectiousdose.com. Marked explicit for limited and mild profanity.By pathogenperspectives

1
Episode 2: Other COVID-19 Vaccine Platforms 38:11

2M ago38:11

38:11

This is the original Pathogen Perspectives episode rebranded for Infectious Dose, originally published in 2020. Heather provides an in-depth discussion on the COVID-19 vaccine platforms other than mRNA, that were in clinical trials around the world. These include self-replicating mRNA, DNA, Protein-based, Attenuated virus, Inactivated virus, Repurp…

1
Episode 1: mRNA COVID Vaccines Explained 25:34

2M ago25:34

25:34

This is the original Pathogen Perspectives Episode published in 2020, rebranded for Infectious Dose. Heather provides an in-depth discussion on the COVID-19 mRNA vaccines authorized for emergency use in the US. She covers: · What is mRNA · How mRNA vaccines work · How we know they are safe · Why they cannot change your DNA · How long might immunity…

1
All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 51:06

3M ago51:06

51:06

In this virtual CE Concepts Grand Rounds, expert faculty will discuss strategies to better integrate diagnostic and prognostic biomarkers for DLBCL, utilize an evidence-based approach for personalizing treatment for patients with R/R DLBCL, and identify and mitigate the impact of AEs associated with novel therapies used in the treatment of patients…

1
Advancements in the Management of Relapsed/Refractory B-Cell Malignancies – Integrating Recent Data into Practice to Improve Outcomes 51:52

4M ago51:52

51:52

In this CE Concepts Grand Rounds podcast, expert faculty will explore the latest clinical trial data on novel treatment options for patients with resistant/recurrent (R/R) CLL/SLL, utilization of an evidence-based approach for personalizing treatment for patients with R/R MCL, and prioritization of patient adherence and active engagement through de…

1
All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma 41:21

6M ago41:21

41:21

Peripheral T-cell lymphomas (PTCLs) are a diverse collection of non-Hodgkin lymphomas that make treatment and patient-centered care challenging, and highlight the need for targeted therapies based on molecular and genetic profiling to enhance treatment efficacy and reduce treatment-related adverse events (TRAEs). The role of CD30 expression further…

1
All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives 1:00:36

9M ago1:00:36

1:00:36

The reduced incidence of cervical cancer over the past few decades was primarily due to robust screening guidelines and vaccinations. However, despite the proliferation of screening programs, the diagnosis of cervical cancer is associated with inefficiencies and inconsistencies and has not decreased cervical cancer incidence further over the past d…

1
All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches 46:40

9M ago46:40

46:40

Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway inhibition is the standard of care for patients with symptomatic myelofibrosis (MF); however, a significant number of hematologists/oncologists lack knowledge, competence, and confidence about JAK inhibitors (JAKis) in MF. These clinicians and their interdisciplinary c…

1
Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team 1:18:19

9M ago1:18:19

1:18:19

The treatment paradigm in bladder cancer has fundamentally changed over the past decade, and the evolving, dense clinical trial landscape has given rise to barriers to optimizing patient care. This webcast will focus on emerging trial data for antibody-drug conjugates (ADCs); sequence optimization, combinatorial therapy utilization, and identificat…

1
Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer 50:54

11M ago50:54

50:54

Patients with triple-negative and HR-positive/HER2-negative breast cancer have limited treatment options after the development of endocrine resistance. This dearth of options is particularly acute for Black women and other marginalized patients and results in treatment disparities. Antibody-drug conjugates (ADCs) are novel agents which may improve …

1
Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies 1:33:21

11M ago1:33:21

1:33:21

Patients with triple-negative breast cancer (TNBC), and those with HR-positive/HER2-negative breast cancer after the development of endocrine resistance, have limited treatment options. Black women are diagnosed more often with TNBC and feel the lack of treatment options more acutely, leading to greater outcomes disparities. Antibody-drug conjugate…

1
Navigating New Waters for Advanced or Recurrent Endometrial Cancer 1:06:48

11M ago1:06:48

1:06:48

Patient prognosis for endometrial cancer (EC) is highly benefited by molecular profiling, and national and international guidelines robustly recommend its integration into practice. Characterization of DNA mismatch repair (MMR) status identifies clinically significant molecular subtypes. This information assists clinicians in creating treatment pla…

1
Cancer-Associated VTE: Balancing Risk and Reward with Modern Anticoagulation 50:27

1y ago50:27

50:27

Reducing barriers to adequate anticoagulation for patients with cancer improves outcomes for those with cancer-associated venous thromboembolisms (CA-VTEs). Advances in cancer treatments and the resulting improvements in patient survival have led to an increase in the number of patients with cancer who develop a VTE at some point during their treat…

1
Actionable Strategies in Community Oncology to Achieve Equity in Triple-Negative Breast Cancer 54:13

1+ y ago54:13

54:13

This podcast focuses on educating, informing, and empowering clinicians involved in the care of patients with triple-negative breast cancer (TNBC) to positively impact the racial/ethnic disparities that negatively impact Black women. Our faculty will explore strategies that promote equitable care and outcomes for all patients; evaluate the role of …

1
Primary Care Perspectives on Obesity: Embracing Novel Agents to Optimize Patient Outcomes 37:03

1+ y ago37:03

37:03

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/activity/primary-care-perspectives-on-obesity-embracing-novel-agents-to-optimize-patient-outcomes-2/ This podcast reviews the etiology and epidemiology of obesity, as well as prominent unmet needs and barriers to treatment optimizatio…

1
Meeting Complex Challenges in Proteinuric Glomerular Disease: An Expert Review of Emerging Data and Novel Therapeutics for IgA Nephropathy 56:24

2y ago56:24

56:24

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/igan-ee-podcast This activity will take learners on a deep dive into the pathophysiology of proteinuric glomerular disease, with an incisive focus on IgA nephropathy (IgAN). Expert faculty will review the totality of emerging evidence…

1
Bridging Chasms in Bladder Cancer Care: An Expert Case-based Review of Treatment Selection and Sequencing in an Era of Therapeutic Novelty 1:30:56

2+ y ago1:30:56

1:30:56

By Drs. Grivas, Chang, and Tagawa

1
Nephrology Nursing Insights for Managing Chronic Kidney Disease–associated Pruritus: Embracing Evolving Data and Emerging Agents to Optimize Outcomes 41:04

2+ y ago41:04

41:04

This educational activity will meet nephrology nurses where they are and provide them with expert insights into CKD-aP prevalence, patient burden, therapeutic rationale, and pivotal principles for safely and effectively integrating novel treatments into practice. The role of the nurse as a premier patient-facing care provider will be emphasized thr…

1
Navigating Novel Terrain in Anemia of Chronic Kidney Disease: A Patient-centric Review of Disease State, Current Chasms in Care, and the Future Promise of HIF-PH Inhibition 1:16:11

2+ y ago1:16:11

1:16:11

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/navigating-ckd-podcast#group-tabs-node-course-default1 To facilitate timely diagnosis and rapid treatment initiation for anemia in CKD, the multidisciplinary and interprofessional CKD-anemia treatment team should be aware of the signi…

1
Nephrology Nurse Viewpoints on In-hospital Hyperkalemia Management: Improving Patient Outcomes in Acute Care Settings with Novel Potassium Binders 57:39

2+ y ago57:39

57:39

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/hk-ch-podcast Learning Objectives Appraise key mechanisms of potassium homeostasis and review patient-centric risk factors for hyperkalemia. Discuss the prevalence and clinical gravity of hyperkalemia, with emphasis on acute care chal…

1
Harnessing the Power of Immunotherapy in HCC and BTC: An Expert Exploration of the Past, Present, and Future of Checkpoint Inhibition 1:02:45

2+ y ago1:02:45

1:02:45

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/sitc22-podcast This session will review the totality of emerging evidence for immune checkpoint inhibitors (ICIs) in the hepatocellular carcinoma (HCC) and biliary tract cancer (BTC) management calculus. Faculty will highlight the par…

1
IV Iron Expert Exchange: Data-driven Debates on the Revolutionary Role of IV Iron in Heart Failure 1:36:50

2+ y ago1:36:50

1:36:50

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/iv-iron-expert-exchange-podcast In this Expert Exchange-based format, activity attendees will be immersed in a lively discussion between key thought leaders in the world of HF. Expert discussion will include an exploration of clinical…

1
Pulmonology Perspectives on Biomarker Testing in NSCLC: Multidisciplinary Management in an Era of Rapid Change 1:47:28

2+ y ago1:47:28

1:47:28

To receive up to 2.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/2022chest-podcast This dynamic live symposium, led by top experts in the field of pulmonary medicine and NSCLC, will take attendees on a deep dive into the sentinel role of the pulmonologist in the NSCLC management paradigm, exploring…

1
Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease 1:01:59

2+ y ago1:01:59

1:01:59

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/ebc-gr-podcast Learning Objectives Review the epidemiology and clinical characteristics of HR+, HER2- early-breast cancer (EBC), and identify patients at an elevated risk of disease recurrence as a means of guiding treatment. Appraise…

1
Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm 40:56

2+ y ago40:56

40:56

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/ovarian-gr-podcast Learning Objectives Review recent updates to national guideline recommendations in ovarian cancer treatment and testing and discuss health equity issues that may hinder ovarian cancer patients from receiving the cur…

1
Overcoming Pediatric Iron Deficiency Anemia with IV Iron: Interprofessional Approaches to Integrating New Data, Using Novel Agents, and Optimizing Care 53:32

2+ y ago53:32

53:32

To receive up to 1.0 CME/CE credit please complete the evaluation and request form here: https://www.ceconcepts.com/iv-gr-podcast#group-tabs-node-course-default1 Learning Objectives Review the clinical gravity and foundational pathophysiology of iron deficiency anemia (IDA) in pediatric patients, with an emphasis on patient impact and the need for …

1
New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy 1:00:04

3y ago1:00:04

1:00:04

Join our Expert Faculty, Drs. Joel W. Neal, MD, PhD and Victoria Sherry, DNP, CRNP, AOCNP as they discuss treatment principles across the continuum of care in unresectable, stage III NSCLC. During their presentations and discussion, they will examine the established treatment landscape for unresectable, stage III NSCLC as well as the emerging role …

1
Optimizing Cancer-related Anemia Outcomes in the Community Setting: Interprofessional Approaches and Evidence-supported Strategies for Improving Care with Intravenous Iron 49:32

3y ago49:32

49:32

Learning Objectives Review the formative facets of iron absorption and metabolism, including the practical distinctions between functional and absolute iron deficiency, with expert analysis of how these principles dictate treatment approaches. Summarize the multifactorial etiologies and complex pathophysiology of cancer-related anemia (CRA) and che…

1
Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface 1:02:15

3y ago1:02:15

1:02:15

All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies. The vicious cycle of cardiorenal anemia syndrome (CRAS)—the pathologic triad wherein the thr…

1
2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access 1:11:33

3y ago1:11:33

1:11:33

This Rapid Recap will provide a responsive, timely, and incisive overview of data presented at the 2022 Clinical Oncology Annual Meeting, and offer expert insights into the shifting management landscape for metastatic EGFR+ NSCLC. These data will be placed in context of the established paradigm, with key scientific messages and pivotal points highl…

1
Overcoming Disparity with Novelty in Triple-Negative Breast Cancer: Community Oncology Perspectives on Promoting Equity and Improving Clinical Outcomes 50:21

3y ago50:21

50:21

Learning Objectives Discuss the multifaceted etiology of the racial disparity observed in triple-negative breast cancer (TNBC), with a focus on both biologic and non-biologic factors, and identify tangible strategies community-based clinicians can employ to promote equitable care and outcomes for all patients. Review antibody-drug conjugate (ADC) s…

1
Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The Oncology Nurse 1:21:08

3y ago1:21:08

1:21:08

This symposium will explore the latest ovarian cancer guideline recommendations and recent evidence for PARP inhibitors in treatment and maintenance settings. The nurse’s role in facilitating access to quality care for those with disparities, the unique toxicity profiles of PARP inhibitors, and how to mitigate, anticipate, and manage toxicities tha…

1
Cure, Prevent, or Manage All Disease: The Chan Zuckerberg Initiative's Bold Plan Is Already Working 36:32

3y ago36:32

36:32

Dr Eric Topol sits down with Mark Zuckerberg and Priscilla Chan to talk about the next phase of their ambitious Chan Zuckerberg Initiative. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https://www.medscape.com/viewarticle/971847 CZ Biohub: https://www.czbiohub.o…

1
Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for the Interprofessional Healthcare Team 47:17

3y ago47:17

47:17

This activity will review the failure rates of traditional therapies for DLBCL, such as R-CHOP, and evaluate patient-centric factors that contribute to disease progression and/or relapse. Expert faculty will then guide attendees through an evidence-based examination of the exigent need for more effective front-line therapeutic options in DLBCL, emp…

1
Interprofessional Perspectives on the Evolving Heart Failure Treatment Paradigm: Harnessing Novel Therapeutics to Optimize Outcomes & Overcome Disparities in Care 38:32

3y ago38:32

38:32

This activity will review how social determinants of health have led to inequities and disparate outcomes in HF. Attendees will take part in an expert-led exploration of current treatment guidelines, with an emphasis on HFrEF, and a review of emerging novel therapeutics. Learners will review real-world cases, empowering them to effectively interpol…

1
Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: An Expert-Led Exploration of Recent and Emerging Trial Data and Current Guideline Recommendations 46:27

3y ago46:27

46:27

Credit is no longer available, however, you can still access and learn from this podcast! This Medical Moments webinar will review all clinically relevant aspects of cancer-related anemia (CRA) management, including chemotherapy-induced anemia (CIA). The activity will begin with a brief primer on iron metabolism and absorption principles, including…

Podcasts Worth a Listen

Herd Immunity Podcasts

Podcasts Worth a Listen

Quick Reference Guide